NEW TEST MAY HELP PATIENTS AVOID UNNECESSARY CHEMO

[Guest guest]

Hmm, " . . . the most commonly used breast cancer chemotherapy regimen

almost certainly provides no benefit whatever to 92 percent of

patients. " Gee, what a surprise.

 

(Cancer Decisions News Staff)

 

Ralph W. Moss, Ph.D. Weekly CancerDecisions.com

Newsletter #295 07/01/07

 

THE MOSS REPORTS - CANCER DECISIONS NEWSLETTER

 

NEW TEST MAY HELP PATIENTS AVOID UNNECESSARY CHEMO

 

Current research indicates that the most commonly used breast cancer

chemotherapy regimen almost certainly provides no benefit whatever to 92

percent of patients. A test is now being developed to identify the 8

percent of women who have the greatest chance of benefiting from

chemotherapy.

 

To read or listen to this week's newsletter, please click here or go to:

http://www.cancerdecisions.com/070107.html